Amrize Ltd $AMRZ Stock Acquired by CenterBook Partners LP

CenterBook Partners LP raised its position in Amrize Ltd (NYSE:AMRZ) by 1,123.6% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 101,408 shares of the company’s stock after purchasing an additional 93,120 shares during the period. CenterBook Partners LP’s holdings in Amrize were worth $3,792,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Amundi boosted its stake in Amrize by 30.9% during the 1st quarter. Amundi now owns 1,654,739 shares of the company’s stock worth $92,698,000 after purchasing an additional 390,750 shares during the last quarter. DJE Kapital AG raised its position in shares of Amrize by 45.9% in the first quarter. DJE Kapital AG now owns 1,113,036 shares of the company’s stock valued at $60,194,000 after buying an additional 350,149 shares during the last quarter. Great Lakes Advisors LLC acquired a new stake in shares of Amrize in the second quarter valued at about $16,975,000. Ancora Advisors LLC acquired a new stake in shares of Amrize in the second quarter valued at about $15,112,000. Finally, Assetmark Inc. lifted its stake in shares of Amrize by 18,567.2% in the first quarter. Assetmark Inc. now owns 250,887 shares of the company’s stock worth $14,055,000 after buying an additional 249,543 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on AMRZ shares. Stephens lowered their price target on shares of Amrize from $65.00 to $54.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 12th. Weiss Ratings lowered shares of Amrize from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, October 8th. Longbow Research assumed coverage on shares of Amrize in a research note on Monday, October 12th. They issued a “buy” rating on the stock. JPMorgan Chase & Co. lowered their target price on Amrize from $52.00 to $48.00 and set a “neutral” rating on the stock in a report on Tuesday, October 13th. Finally, Truist Financial dropped their price target on Amrize from $48.00 to $35.00 and set a “hold” rating for the company in a research report on Monday, October 5th. Eight analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $49.06.

Insider Activity at Amrize

In other news, insider Mario Gross bought 3,568 shares of the firm’s stock in a transaction on Tuesday, August 11th. The shares were bought at an average cost of $46.60 per share, for a total transaction of $166,268.80. Following the acquisition, the insider directly owned 38,485 shares of the company’s stock, valued at $1,793,401. This trade represents a 10.22% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Stephen Clark purchased 5,260 shares of the company’s stock in a transaction dated Tuesday, August 11th. The stock was purchased at an average cost of $47.31 per share, with a total value of $248,850.60. Following the purchase, the insider owned 10,637 shares in the company, valued at approximately $503,236.47. This trade represents a 97.82% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders bought 48,983 shares of company stock valued at $2,158,755 over the last ninety days. Corporate insiders own 0.54% of the company’s stock.

Amrize Stock Down 1.8%

NYSE AMRZ opened at $41.90 on Friday. Amrize Ltd has a 52 week low of $35.78 and a 52 week high of $65.94. The company has a quick ratio of 0.67, a current ratio of 1.07 and a debt-to-equity ratio of 0.33. The business’s fifty day simple moving average is $39.53 and its 200-day simple moving average is $50.30. The firm has a market cap of $23.17 billion, a PE ratio of 18.96, a P/E/G ratio of 1.64 and a beta of 0.04.

Amrize (NYSE:AMRZ) last announced its quarterly earnings results on Wednesday, October 28th. The company reported $1.05 earnings per share for the quarter, meeting the consensus estimate of $1.05. Amrize had a net margin of 9.93% and a return on equity of 10.02%. The firm had revenue of $3.77 billion for the quarter. During the same period in the previous year, the firm posted $0.98 EPS. The company’s revenue was up 2.6% compared to the same quarter last year. As a group, equities analysts anticipate that Amrize Ltd will post 2.30 earnings per share for the current year.

Amrize Announces Dividend

The company also recently announced a dividend, which will be paid on Wednesday, November 18th. Shareholders of record on Tuesday, November 10th will be paid a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, November 10th. Amrize’s payout ratio is 4.98%.

Amrize Profile

Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets.

The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects.

Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim’s North American business.